Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CGEM stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CGEM investment potential.

What is CGEM stock price today?

Get real-time CGEM stock price, historical data, and price charts on Financhill. Track CGEM performance with our advanced analysis tools.

Is CGEM a good investment?

Evaluate CGEM investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CGEM stock?

To buy CGEM stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CGEM?

View detailed market capitalization data and company valuation metrics for CGEM on our comprehensive analysis page.

What is the P/E ratio of CGEM?

Use our fundamental analysis tools to view CGEM P/E ratio and compare valuation metrics with industry peers.

What are CGEM earnings?

View CGEM earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cullinan Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

CGEM
Cullinan Therapeutics, Inc.

Last Price:

$10.33

Seasonality Move:

11%

7 Day Trial

ALL ACCESS PASS

$ 7

Cullinan Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Cullinan Therapeutics, Inc. has on average historically fallen by 7.6% based on the past 4 years of stock performance.
Cullinan Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is Cullinan Therapeutics, Inc. Stock Undervalued?

The current Cullinan Therapeutics, Inc. [CGEM] share price is $9.68. The Score for CGEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
CGEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cullinan Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Cullinan Therapeutics, Inc. has on average historically fallen by 7.6% based on the past 4 years of stock performance.

Cullinan Therapeutics, Inc. Stock Rating

Sell

Cullinan Therapeutics, Inc. (CGEM) is a Sell

Is Cullinan Therapeutics, Inc. overpriced?

Cullinan Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Cullinan Therapeutics, Inc. Stock Price History

Is CGEM stock going to rise?

The current trend is relatively stagnant and CGEM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

cullinantherapeutics.com

52-Week Data

52-Week High:

13.33

52-Week Low:

5.68

Prediction Charts

Market Cap:

571.9M

Price in USD:

9.68

Volume:

1.9M

Beta:

-0.10

Technical Analysis

SMA50:

9.26

SMA100:

8.10

SMA200:

8.09

52-Wk Change:

-11.6%

Stock Predictions

Is Cullinan Therapeutics, Inc. stock public?

Yes, Cullinan Therapeutics, Inc. is a publicly traded company.
What is the Cullinan Therapeutics, Inc. stock quote today?

The Cullinan Therapeutics, Inc. stock price is 9.68 USD today.
How to buy Cullinan Therapeutics, Inc. stock online?

You can buy Cullinan Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-2	10.73	10.20	11.15	10.13
Dec-3	10.18	10.50	10.68	10.01
Dec-4	10.43	10.58	10.79	10.08
Dec-5	10.69	10.59	10.80	10.28
Dec-8	10.89	12.44	12.71	10.56
Dec-9	12.44	12.36	12.88	11.90
Dec-10	12.77	12.46	12.85	12.11
Dec-11	12.45	12.38	13.10	12.04
Dec-12	12.38	11.92	12.94	11.90
Dec-15	11.90	10.82	12.09	10.76
Dec-16	10.96	10.22	11.23	10.08
Dec-17	10.20	9.59	10.37	9.48
Dec-18	9.67	9.98	10.09	9.60
Dec-19	10.10	9.68	10.14	9.61

Cullinan Therapeutics, Inc. Earnings

Cullinan Therapeutics, Inc. Earnings Report: Per Share Cullinan Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cullinan Therapeutics, Inc. Forecast Revenue Growth

Cullinan Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cullinan Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.29 per share.

* Cullinan Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.